Hong Yuan Holding (HGYN) 10-Q 13 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 08, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-56252
Entity Registrant Name	HONG YUAN HOLDING GROUP
Entity Central Index Key	0001324759
Entity Tax Identification Number	91-2154289
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	Room 2707, Global Mansion
Entity Address, Address Line Two	Zhengbian Road
Entity Address, Address Line Three	Jinhui District
Entity Address, City or Town	Zhengzhou City
Entity Address, Country	CN
Entity Address, Postal Zip Code	450000
City Area Code	+861
Local Phone Number	8999250338
Title of 12(b) Security	Common Stock
Trading Symbol	HGYN
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		74,640,766

Balance Sheets

Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
ASSETS
TOTAL ASSETS
Current Liabilities
Accounts payable and accrued liabilities	2,462	1,833
Due to related parties	140,481	109,691
Total Current Liabilities	142,943	111,524
TOTAL LIABILITIES	142,943	111,524
Stockholders’ Deficit
Preferred Stock: 5,000,000 shares authorized; $0.001 par value 5,000,000 issued and outstanding at September 30, 2023 and December 31, 2022	5,000	5,000
Common stock: 250,000,000 shares authorized; $0.001 par value 74,640,766 shares issued and outstanding at September 30, 2023 and December 31, 2022	74,641	74,641
Additional Paid-in Capital	97,186,036	97,186,036
Accumulated deficit during development stage	(97,408,620)	(97,377,201)
Total Stockholders’ Deficit	(142,943)	(111,524)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	5,000,000	5,000,000
Preferred stock, shares outstanding	5,000,000	5,000,000
Common stock, shares authorized	250,000,000	250,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	74,640,766	74,640,766
Common stock, shares outstanding	74,640,766	74,640,766

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating Expenses
General and administrative	$ 60	$ 30	$ 150	$ 5,109
Professional fees	10,106	9,895	31,269	30,926
Total Operating Expenses	10,166	9,925	31,419	36,035
Operating loss	(10,166)	(9,925)	(31,419)	(36,035)
Other Income and Expense
Provision for income taxes
Net loss	$ (10,166)	$ (9,925)	$ (31,419)	$ (36,035)
Basic net loss per common share	$ 0	$ 0	$ 0	$ 0
Dilutive net loss per common share	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares outstanding - basic	74,640,766	74,640,766	74,640,766	74,640,766
Weighted average number of common shares outstanding - diluted	74,640,766	74,640,766	74,640,766	74,640,766

Statements of Stockholders' Equ

Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Preferred Stock [Member] Series A1 Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2021	$ 74,641	$ 5,000	$ 97,186,036	$ (97,318,835)	$ (53,176)
Balance, shares at Dec. 31, 2021	74,640,776	5,000,000
Net loss				(26,110)	(26,110)
Balance at Jun. 30, 2022	$ 74,641	$ 5,000	97,186,036	(97,344,963)	(79,286)
Balance, shares at Jun. 30, 2022	74,640,766	5,000,000
Balance at Dec. 31, 2021	$ 74,641	$ 5,000	97,186,036	(97,318,835)	(53,176)
Balance, shares at Dec. 31, 2021	74,640,776	5,000,000
Net loss					(36,035)
Balance at Sep. 30, 2022	$ 74,641	$ 5,000	97,186,036	(97,354,888)	(89,211)
Balance, shares at Sep. 30, 2022	74,640,766	5,000,000
Balance at Jun. 30, 2022	$ 74,641	$ 5,000	97,186,036	(97,344,963)	(79,286)
Balance, shares at Jun. 30, 2022	74,640,766	5,000,000
Net loss				(9,925)	(9,925)
Balance at Sep. 30, 2022	$ 74,641	$ 5,000	97,186,036	(97,354,888)	(89,211)
Balance, shares at Sep. 30, 2022	74,640,766	5,000,000
Balance at Dec. 31, 2022	$ 74,641	$ 5,000	97,186,036	(97,377,201)	(111,524)
Balance, shares at Dec. 31, 2022	74,640,766	5,000,000
Net loss				(21,253)	(21,253)
Balance at Jun. 30, 2023	$ 74,641	$ 5,000	97,186,036	(97,398,454)	(132,777)
Balance, shares at Jun. 30, 2023	74,640,766	5,000,000
Balance at Dec. 31, 2022	$ 74,641	$ 5,000	97,186,036	(97,377,201)	(111,524)
Balance, shares at Dec. 31, 2022	74,640,766	5,000,000
Net loss					(31,419)
Balance at Sep. 30, 2023	$ 74,641	$ 5,000	97,186,036	(97,408,620)	(142,943)
Balance, shares at Sep. 30, 2023	74,640,766	5,000,000
Balance at Jun. 30, 2023	$ 74,641	$ 5,000	97,186,036	(97,398,454)	(132,777)
Balance, shares at Jun. 30, 2023	74,640,766	5,000,000
Net loss				(10,166)	(10,166)
Balance at Sep. 30, 2023	$ 74,641	$ 5,000	$ 97,186,036	$ (97,408,620)	$ (142,943)
Balance, shares at Sep. 30, 2023	74,640,766	5,000,000

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (10,166)	$ (9,925)	$ (21,253)	$ (26,110)	$ (31,419)	$ (36,035)
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities					629	900
Due to related party					30,790	35,135
Net Cash Used in Operating Activities
CASH FLOWS FROM INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES
Net change in cash and cash equivalents for the year
Cash and cash equivalents at beginning of the year
Cash and cash equivalents at end of the year
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes
Cash paid for interest

Organization and basis of accou

Organization and basis of accounting	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and basis of accounting	Note 1 – Organization and basis of accounting Basis of Presentation and Organization This summary of significant accounting policies of Hong Yuan Holding Group. (a development stage company) (“the Company”) is presented to assist in understanding the Company’s financial statements. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the accompanying financial statements. The Company has realized minimal revenues from its planned principal business purpose and, accordingly, is considered to be in its development stage in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic No. 915 (SFAS No. 7). The Company has elected a fiscal year end of December 31. Business Description We were incorporated on September 29, 2001 in the State of Nevada under the name of Biocorp North America Inc. On March 18, 2005, we filed an amendment to our certificate of incorporation to change our name to Cereplast, Inc. On February 10, 2014, the Company, filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Indiana (the “Bankruptcy Court “). On February 14, 2014, the Company filed a motion in the Bankruptcy Court seeking to convert the Company’s Chapter 11 Case to a Chapter 7 bankruptcy case. On March 27, 2014, the court granted the Company’s motion and on that date the Company’s Chapter 11 Case was converted to a Chapter 7 case. As a result, the Company adopted liquidation basis of accounting on the discontinued operations according to ASC 205-30 “Presentation of Financial Statements – Liquidation Basis of Accounting”, accordingly the accumulated deficit generated prior to bankruptcy proceedings remained unadjusted. On January 31, 2014, the Board of Directors of Cereplast, Inc. (the “Company”) approved a 1-for-50 On February 3, 2014, Cereplast, Inc. (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation to effect the reverse split (the “Reverse Split”), effective as of February 21, 2014. On March 22, 2019, the eight judicial District Court of Nevada appointed Custodian Ventures, LLC as custodian for Cereplast, Inc., proper notice having been given to the officers and directors of Cereplast, Inc. There was no opposition. On June 04, 2019, the Company filed a certificate of revival with the state of Nevada, appointing David Lazar as, President, Secretary, Treasurer and Director. On October 4, 2019, the Company issued 50,000,000 50,000 20,100 29,900 3 180 On April 14, 2020, Custodian Ventures elected to convert the total amount of the 510 510 On April 15, 2020, the Board of directors of the Company approved the withdrawal of the certificate of designation of 5,000,000 On May 1, 2020, the Company created 5,000,000 shares of series A-1 preferred stock with par value $ 0.001 . On May 4, 2020, the Company issued 5,000,00 shares of the Series A-1 Preferred stock valued at $ 5,000 A change of control of the Company was completed on November 3, 2020, control was obtained by the sale of 50,000,000 5,000,000 On November 18, 2020, the Company filed an amendment to its certificate of incorporation to change its name to Hong Yuan Holding Group. The accompanying financial statements are prepared on the basis of accounting principles generally accepted in the United States of America (“GAAP”). The Company is a development stage enterprise devoting substantial efforts to establishing a new business, financial planning, raising capital, and research into products which may become part of the Company’s product portfolio. The Company has not realized significant sales since inception. A development stage company is defined as one in which all efforts are devoted substantially to establishing a new business and, even if planned principal operations have commenced, revenues are insignificant. The Company is planning potential acquisitions. The management has approached several companies in China and met the management of potential acquisition targets. The Company feels strongly that despite the challenges of cross border business, it might be able to acquire some good growth companies and bring good values to our stockholders. Although the Company is making some progress in the Merger and Acquisition efforts, any potential results, if any, are still not certain. The accompanying financial statements have been prepared assuming the continuation of the Company as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating to an equity funding facility is in effect. While management of the Company believes that it will be successful in its capital formation and planned operating activities, there can be no assurance that the Company will be able to raise additional equity capital, or be successful in the development and commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Summary of significant accounti

Summary of significant accounting policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Summary of significant accounting policies	Note 2 – Summary of significant accounting policies Unaudited Interim Financial Information These unaudited interim financial statements have been prepared in accordance with GAAP for interim financial reporting and the rules and regulations of the Securities and Exchange Commission that permit reduced disclosure for interim periods. Therefore, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented have been made. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2023. The balance sheets and certain comparative information as of December 31, 2022 are derived from the audited financial statements and related notes for the year ended December 31, 2022, included in the Company’s Form 10K. These unaudited interim financial statements should be read in conjunction with the annual consolidated financial statements and the accompanying notes contained in our Form 10K. Covid – 19 On March 11, 2020, the World Health Organization announced that infections caused by the corona virus disease of 2019 (“COVID-19”) had become pandemic. The Government of China has adopted various regulations and orders, including mandatory quarantines, limits on the number of people that may gather in one location, closing non-essential businesses and travel bans to limit the spread of the disease. Many of these measures have been relaxed due to the decrease in the prevalence of Covid-19 in China. The Company’s efforts to establishing a new business, financial planning, raising capital, and research into products for the Company’s product portfolio has somewhat impacted by COVID-19. Cash and Cash Equivalents For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. Employee Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC 718 Compensation - Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations. Loss per Share Basic earnings (loss) per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the nine months ended September 30, 2023 and 2022, as there are no potential shares outstanding that would have a dilutive effect. Income Taxes Income tax expense is based on pretax financial accounting income. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. The Company recorded a valuation allowance against its deferred tax assets as of September 30, 2023 and December 31, 2022. The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3- Going Concern The accompanying financial statements have been prepared assuming the continuation of the Company as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating to an equity funding facility is in effect. While management of the Company believes that it will be successful in its capital formation and planned operating activities, there can be no assurance that the Company will be able to raise additional equity capital or be successful in the development and commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Related party transaction

Related party transaction	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
Related party transaction	Note 4 – Related party transaction During the nine months ended September 30, 2023, the Company’s current majority shareholder advanced $ 30,790 140,481 109,691

Common stock

Common stock	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Common stock	Note 5 – Common stock At September 30, 2023, the Company is authorized to issue 250,000,000 0.001 As of September 30, 2023, a total of 74,640,766 0.001

Preferred stock

Preferred stock	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Preferred stock	Note 6 – Preferred stock As of September 30, 2023, a total of 5,000,000 0.001

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 7 – Income Taxes Deferred taxes represent the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes. Temporary differences result primarily from the recording of tax benefits of net operating loss carry forwards. As of September 30, 2023, the Company has an insufficient history to support the likelihood of ultimate realization of the benefit associated with the deferred tax asset. Accordingly, a valuation allowance has been established for the full amount of the net deferred tax asset. Uncertain Tax Positions Interest associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative expenses in the statements of operations. For the nine months ended September 30, 2023 and 2022, the Company had no

Subsequent Event

Subsequent Event	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Event	Note 8 – Subsequent Event In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.

Summary of significant accoun_2

Summary of significant accounting policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Unaudited Interim Financial Information	Unaudited Interim Financial Information These unaudited interim financial statements have been prepared in accordance with GAAP for interim financial reporting and the rules and regulations of the Securities and Exchange Commission that permit reduced disclosure for interim periods. Therefore, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented have been made. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2023. The balance sheets and certain comparative information as of December 31, 2022 are derived from the audited financial statements and related notes for the year ended December 31, 2022, included in the Company’s Form 10K. These unaudited interim financial statements should be read in conjunction with the annual consolidated financial statements and the accompanying notes contained in our Form 10K.
Covid – 19	Covid – 19 On March 11, 2020, the World Health Organization announced that infections caused by the corona virus disease of 2019 (“COVID-19”) had become pandemic. The Government of China has adopted various regulations and orders, including mandatory quarantines, limits on the number of people that may gather in one location, closing non-essential businesses and travel bans to limit the spread of the disease. Many of these measures have been relaxed due to the decrease in the prevalence of Covid-19 in China. The Company’s efforts to establishing a new business, financial planning, raising capital, and research into products for the Company’s product portfolio has somewhat impacted by COVID-19.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.
Employee Stock-Based Compensation	Employee Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC 718 Compensation - Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations.
Loss per Share	Loss per Share Basic earnings (loss) per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the nine months ended September 30, 2023 and 2022, as there are no potential shares outstanding that would have a dilutive effect.
Income Taxes	Income Taxes Income tax expense is based on pretax financial accounting income. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. The Company recorded a valuation allowance against its deferred tax assets as of September 30, 2023 and December 31, 2022. The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.

Organization and basis of acc_2

Organization and basis of accounting (Details Narrative) - USD ($)	Nov. 03, 2020	May 04, 2020	Apr. 14, 2020	Oct. 04, 2019	Jan. 31, 2014	Sep. 30, 2023	Dec. 31, 2022	May 01, 2020	Apr. 15, 2020
Reverse stock split, description					1-for-50
Preferred stock, shares authorized						5,000,000	5,000,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001	$ 0.001
Common Stock [Member]
Conversion of stock, shares converted			510
Sale of stock, shares	50,000,000
Series A Preferred Stock [Member]
Preferred stock, convertible, shares issuable			510
Preferred stock, shares authorized									5,000,000
Series A1 Preferred Stock [Member]
Preferred stock, shares authorized								5,000,000
Preferred Stock, Par or Stated Value Per Share						$ 0.001		$ 0.001
Proceeds from sale of stock	$ 5,000,000
Custodian Ventures, LLC [Member] | Common Stock [Member]
Shares issued, shares				50,000,000
Shares issued, value				$ 50,000
Settlement loan amount				20,100
Note receivable due				$ 29,900
Interest rate				3%
Notes matures				180 days
Custodian Ventures, LLC [Member] | Series A1 Preferred Stock [Member]
Shares issued, shares		5,000
Shares issued, value		$ 5,000

Summary of significant accoun_3

Summary of significant accounting policies (Details Narrative)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Income tax examination, description	The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.

Related party transaction (Deta

Related party transaction (Details Narrative) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Due to related parties	$ 140,481	$ 109,691
Majority Shareholder [Member]
Related Party Transaction [Line Items]
Due from related party	30,790
Due to related parties	$ 140,481	$ 109,691

Common stock (Details Narrative

Common stock (Details Narrative) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Equity [Abstract]
Common stock, shares authorized	250,000,000	250,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	74,640,766	74,640,766

Preferred stock (Details Narrat

Preferred stock (Details Narrative) - $ / shares	Sep. 30, 2023	Dec. 31, 2022	May 01, 2020
Class of Stock [Line Items]
Preferred stock, shares outstanding	5,000,000	5,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Series A1 Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares outstanding	5,000,000
Preferred stock, par value	$ 0.001		$ 0.001

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 0	$ 0